AIOTF buys CPAT Technologies to bring pharma traceability to Africa
What's the deal? AIOTF Software has acquired CPAT TechnologiesDealroom has a profile for this one. Try Dealroom →, a Canadian health-tech firm based in Brampton, Ontario. The deal combines AIOTF's AI inferencing and enterprise platforms with CPAT's GS1-compliant track-and-trace suite. Terms were not disclosed.
What do they do? AIOTF builds AI inferencing, deep-tech, and enterprise posture management platforms. CPAT develops pharmaceutical traceability technology aligned with GS1 standards.
What's the endgame? The combined company will build a track-and-trace system for pharmaceuticals in emerging markets, aiming to eliminate counterfeit medicines and secure supply chains.
Why now? The merged firm will focus on Kenya's National Pharmaceutical Traceability Programme, working with Kenya's Ministry of Health, the Kenya Medical Supplies Authority, and the Pharmacy and Poisons Board.
The rollout follows three phases: setting up batch registries and facility platforms, adding 2D DataMatrix serialization for high-risk products, and reaching full supply chain oversight before expanding across Africa.
What they're saying: "By pairing CPAT's GS1-compliant platform with AIOTF's AI, we will protect millions of lives and eliminate counterfeit medicines across Africa," said Damiano Raveenthiran, chief information officer and founding partner at AIOTF Software.
The signal: The deal positions Kenya as a launchpad for wider African expansion, betting that AI-backed traceability can address counterfeit medicine and supply chain gaps across the continent.
Read more: AP News
Image credit: Generated with Gemini
